Healthcare Industry News Weekly Wrap-Up: August 11, 2022
// Biotech and Pharma Therapeutics Lilly ‘won’t be discouraged’ if others fail in Alzheimer’s, neuroscience chief says August 4, 2022 / Eli Lilly / Donanemab / Alzheimer’s The senior vice president took the firm stance as Lilly announced that donanemab...